Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Ovid Therapeutics Inc.
13G/A
OVID · 690469101
|
12.3% |
12/9/2025
Event 12/8/2025
|
|||
| Takeda Pharmaceutical Company Limited | 12.3% | ||||
| Takeda Pharmaceutical U.S.A., Inc. | 9.8% | ||||
|
Hillevax, Inc.
13D/A
HLVX · 43157M102
|
0% |
9/19/2025
Event 9/17/2025
|
|||
| Takeda Pharmaceutical Company Limited | 0% | ||||
| Takeda Vaccines Inc. | 0% | ||||